Compile Data Set for Download or QSAR
maximum 50k data
Found 295 Enz. Inhib. hit(s) with all data for entry = 11452
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617295(US11753403, Compound I-258)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617296(US11753403, Compound I-65)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617298(US11753403, Compound I-259)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617301(US11753403, Compound I-260)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617131(US11753403, Compound I-111)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617132(US11753403, Compound I-208)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617202(US11753403, Compound I-229)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617304(US11753403, Compound I-261)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617135(US11753403, Compound I-209)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617207(US11753403, Compound I-138)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617308(US11753403, Compound I-262)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617311(US11753403, Compound I-263)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617138(US11753403, Compound I-210)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617139(US11753403, Compound I-17)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617142(US11753403, Compound I-18)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617214(US11753403, Compound I-233)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM616977(US11753403, Compound I-1)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617018(US11753403, Compound I-2)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617058(US11753403, Compound I-3)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617098(US11753403, Compound I-100)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617104(US11753403, Compound I-101)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617106(US11753403, Compound I-6)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617107(US11753403, Compound I-103)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617109(US11753403, Compound I-7)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617110(US11753403, Compound I-104)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617352(US11753403, Compound I-274)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617358(US11753403, Compound I-275)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617170(US11753403, Compound I-27)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617263(US11753403, Compound I-55)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617270(US11753403, Compound I-57)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617375(US11753403, Compound I-87)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617377(US11753403, Compound I-281)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617275(US11753403, Compound I-252)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617276(US11753403, Compound I-59)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617279(US11753403, Compound I-60)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617390(US11753403, Compound I-94)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617380(US11753403, Compound I-282)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617382(US11753403, Compound I-190)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617383(US11753403, Compound I-283)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617289(US11753403, Compound I-256)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617333(US11753403, Compound I-177)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617334(US11753403, Compound I-270)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617164(US11753403, Compound I-25)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617165(US11753403, Compound I-126)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617250(US11753403, Compound I-244)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617251(US11753403, Compound I-51)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617254(US11753403, Compound I-52)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617337(US11753403, Compound I-271)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617259(US11753403, Compound I-247)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617262(US11753403, Compound I-248)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 295 total ) | Next | Last >>
Jump to: